5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.88▲ | 1.89▼ | 1.88▲ | 1.92▼ | 1.90▼ |
MA10 | 1.88▲ | 1.88▲ | 1.89▼ | 1.95▼ | 1.98▼ |
MA20 | 1.88▲ | 1.89▼ | 1.91▼ | 1.94▼ | 2.13▼ |
MA50 | 1.88▲ | 1.94▼ | 1.95▼ | 2.00▼ | 2.12▼ |
MA100 | 1.90▼ | 1.96▼ | 1.98▼ | 2.19▼ | 1.91▼ |
MA200 | 1.95▼ | 1.96▼ | 1.98▼ | 2.23▼ | 4.10▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.003▲ | -0.001▼ | -0.006▼ | -0.038▼ |
RSI | 51.818▲ | 43.669▼ | 39.865▼ | 44.101▼ | 45.312▼ |
STOCH | 86.111▲ | 63.813 | 33.333 | 21.487 | 38.325 |
WILL %R | -25.000▲ | -41.667 | -61.111 | -68.750 | -66.827 |
CCI | 64.167 | 31.111 | -46.205 | -153.309▼ | -88.253 |
▲ GAP | $IKT Open Gap Up %2 | Set Alert |
Thursday, May 15, 2025 05:00 PM
The latest price target for Inhibikase Therapeutics (NASDAQ:IKT) was reported by HC Wainwright & Co. on March 28, 2025. The analyst firm set a price target for $0.00 expecting IKT to fall to ...
|
Sunday, May 11, 2025 05:00 PM
Get Our Latest Analysis on IKT Inhibikase Therapeutics Stock Down 4.8% Shares of Inhibikase Therapeutics stock opened at $2.00 on Monday. The firm has a market cap of $148.68 million, a PE ratio ...
|
Monday, April 14, 2025 05:00 AM
BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 1.905 | 1.905 | 1.85 | 1.885 | 74,013 |
13/06/25 | 1.90 | 1.98 | 1.85 | 1.86 | 92,001 |
12/06/25 | 1.96 | 2.03 | 1.90 | 1.91 | 58,680 |
11/06/25 | 2.05 | 2.05 | 1.94 | 1.96 | 95,621 |
10/06/25 | 2.02 | 2.035 | 1.99 | 2.00 | 129,717 |
09/06/25 | 2.00 | 2.00 | 1.915 | 1.95 | 96,548 |
06/06/25 | 1.98 | 2.005 | 1.91 | 1.96 | 185,188 |
05/06/25 | 1.98 | 2.025 | 1.93 | 1.96 | 111,263 |
04/06/25 | 2.03 | 2.05 | 1.98 | 1.98 | 93,068 |
03/06/25 | 2.06 | 2.13 | 2.02 | 2.03 | 95,042 |
|
|
||||
|
|
||||
|
|